Skip to Content
U.S. National Institutes of Health
Last Updated: 04/15/10

Staff, Pictures and Bios

Meg Mooney, MD, MBA, Branch Chief, CIB, Head - Neuroendocrine tumors, Adult Sarcoma

Meg Mooney, MD, MBA is the Chief of the Clinical Investigations Branch (CIB) of the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, at the NCI and oversees adult sarcoma cancer therapeutics. She was formerly the Interim Director of the Office of Evidence-Based Surgery at the American College of Surgeons in Chicago, Illinois. More…

CAPT Michael Montello, PharmD, MBA, Associate Branch Chief for Clinical Trials Technology

CAPT Michael Montello, PharmD, MBA, is a Pharmacist Consultant in the Clinical Investigations Branch of NCI's Cancer Therapy Evaluation Program and Project Officer of NCI's Cancer Trials Support Unit (CTSU). Mike has extensive project management, clinical trial, pharmacy and disaster response experience. More…

Malcolm A. Smith, MD, PhD, Associate Branch Chief for Pediatric Oncology

Dr. Smith is Associate Branch Chief, Pediatrics in the Clinical Investigations Branch [Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI)]. More…

Jeanne M. Adler, RN, MPH, Head - Central Institution Review Board Strategy and Operations

Jeanne M. Adler, RN, MPH is a Nurse Consultant in the Clinical Investigations Branch of NCI's Cancer Therapy Evaluation Program and Project Officer of NCI's Central IRB Initiative. In addition to her extensive oncology nursing experience, Ms. Adler has expertise in all facets of clinical trial management and has a special interest in ethics and regulatory aspects of biomedical research. More…

Claudio Dansky-Ullmann, MD, Head - Lung Cancer, Thoracic, Head/Neck, Melanoma Cancer Therapeutics

Andrea M. Denicoff, RN, MS, ANP, Nurse Consultant, Clinical Trials Methodology, QOL Specialist

Andrea Denicoff is a Nurse Consultant in the Clinical Investigations Branch within the Cancer Therapy Evaluation Program (CTEP) in the Division of Cancer Treatment & Diagnosis at the National Cancer Institute (NCI). More…

Jacquelyn L. Goldberg, JD, Head - Central Institutional Review Board

Jacquelyn L. Goldberg, JD is the head of the National Cancer Institute's Central IRB Initiative. In addition to her expertise in the ethical and regulatory aspects of biomedical research, she has extensive program and policy experience in women’s health, hospital risk management, and community health planning. More…

Richard F. Little, MD, Head - Hematologic, HIV, and Stem Cell Therapeutics

Dr. Little Joined CTEP as Head of the therapeutics section for Hematologic and AIDS-related Cancers and Hematopoietic Stem Cell April 2007. More…

Bhupinder Mann, MBBS, Head - Genitourinary and Brain Cancer Therapeutics

Dr. Bhupinder Mann joined the Clinical Investigations Branch at CTEP in September 2008. He has the Genitourinary and Brain Cancers therapeutic clinical trials portfolio at CIB/CTEP and is the assigned CIB scientific liaison to the Southwest Oncology Group (SWOG). More…

Nita L. Seibel, MD, Head - Pediatric Solid Tumors

Nita L. Seibel, MD joined the Clinical Investigations Branch of the Cancer Treatment and Evaluation Program in 2008 to oversee the development of the Pediatric Solid Tumor extramural program, long term cancer survivorship, Pediatric Central Institutional Review Board and adolescent and young adult cancer program. More…

Edward L. Trimble, MD, MPH, Head - Gynecologic Cancer Therapeutics and Quality of Cancer Care Therapeutics

Following graduation from Harvard College and the Johns Hopkins University School of Medicine, Edward L. Trimble trained in obstetrics and gynecology at the Vanderbilt University Medical Center. More…

Jack Welch, MD, PhD, Head - GI Cancer Therapeutics

Dr. Welch is the assigned scientific liaison to the Eastern Clinical Oncology Group. Dr. Welch came to CTEP from the European Organisation for the Research and Treatment of Cancer (EORTC), where he was a senior clinical research physician, with a portfolio including gastrointestinal and lung cancers, as well as cutaneous lymphomas. More…

Jo Anne Zujewski, MD, Head - Breast Cancer Therapeutics

Jo Anne Zujewski, MD is the Head - Breast Cancer Therapeutics, in the Clinical Investigation Branch of the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute. In this role, she is the scientific liaison and disease expert for breast cancer clinical trials sponsored by the CTEP program of the NCI. More…